Network analysis and fine-mapping GWAS loci to identify genes and functional variants involved in the development of Dupuytren disease

Kerstin Becker, Juanjiangmeng Du, Peter Nürnberg, Hans Hennies

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

The first genome-wide association study (GWAS) in Dupuytren disease (DD) has successfully identified nine genomic regions that harbor genetic variants contributing to the genetics of this disease. In GWASs common single nucleotide variants (SNVs) are investigated for association with a given trait or disease. These common SNVs are rarely the direct causative variants, but instead by chance, they capture the real causative variants in linkage disequilibrium (LD) at a given association locus. One of the major challenges in complex genetic diseases is the identification of these causal genetic variants that underlie the association signals. Integrative approaches that target the functional relevance of these causal variants on multiple levels are needed. The success of these approaches depends on the individual genetic architecture at each GWAS locus, which can be very complex, and the specific features of a given trait or disease. Targeted sequencing of the GWAS loci is one possible approach. Extensive analysis of GWAS data in conjunction with other possible data sources, e.g., expression data, is another approach to help to unravel the genetics of Dupuytren disease. We have been applying both approaches aiming to interrogate candidate gene variants and to characterize pathways of DD.
Original languageEnglish
Title of host publicationDupuytren Disease and Related diseases
Subtitle of host publicationThe Cutting Edge
EditorsPaul M. N. Werker, Joseph Dias, Charles Eaton, Bert Reichert, Wolfgang Wach
PublisherSpringer Verlag
Pages105-111
Number of pages7
ISBN (Electronic)9783319321998
ISBN (Print)9783319321974
DOIs
Publication statusPublished - 2017
Externally publishedYes

Fingerprint

Dive into the research topics of 'Network analysis and fine-mapping GWAS loci to identify genes and functional variants involved in the development of Dupuytren disease'. Together they form a unique fingerprint.

Cite this